MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma

• Zong-Tao Chai ,

  Contributed equally to this work with: Zong-Tao Chai, Jian Kong

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Jian Kong ,

  Contributed equally to this work with: Zong-Tao Chai, Jian Kong

  Affiliation Department of Hepatobiliary Surgery, Capital Medical University, Beijing Chaoyang Hospital, Beijing, P.R. China

  ⨯
• Xiao-Dong Zhu,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Yuan-Yuan Zhang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Lu Lu,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Jia-Min Zhou,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Long-Rong Wang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Ke-Zhi Zhang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Qiang-Bo Zhang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Jian-Yang Ao,

  Affiliation Department of Hepatobiliary Surgery, Capital Medical University, Beijing Chaoyang Hospital, Beijing, P.R. China

  ⨯
• Miao Wang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Wei-Zhong Wu,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Lu Wang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Zhao-You Tang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯
• Hui-Chuan Sun

  * E-mail: sun.huichuan@zs-hospital.sh.cn

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, P.R. China

  ⨯